PDS Biotechnology Announces Publication Supporting Novel Mechanisms of Action of its Proprietary Versamune® Platform in Cancer Immunotherapy

World News: . []

BERKELEY HEIGHTS NJ May 15 2019 GLOBE LINK  -- PDS Biotechnology Corporation PDS Biotechnology Nasdaq PDSB a clinical-stage immuno-oncology company pioneering the development of multifunctional immunotherapeutic LINK  tod ay anno...

More news and information about PDS Biotechnology Corporation

Published By:

Globe Newswire: 13:30 GMT Wednesday 15th May 2019

Published: .

Search for other references to "biotechnology" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us